2019

  1. Optimized ChIP-seq method facilitates transcription factor profiling in human tumors Singh, Abhishek A, Schuurman, Karianne, Nevedomskaya, Ekaterina, Stelloo, Suzan, Linder, Simon, Droog, Marjolein, Kim, Yongsoo, Sanders, Joyce, Poel, Henk, Bergman, Andries M, and others, Life science alliance 2019
  2. GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice Cornelissen, Lisette M, Bruijn, Roebi, Henneman, Linda, Kim, Yongsoo, Zwart, Wilbert, and Jonkers, Jos Journal of Mammary Gland Biology and Neoplasia 2019
  3. DNA end-resection in highly accessible chromatin produces a toxic break Berg, Jeroen, Joosten, Stacey EP, Kim, YongSoo, Manjón, Anna G, Krenning, Lenno, Koob, Lisa, Feringa, Femke M, Klompmaker, Rob, Broek, Bram, Jalink, Kees, and others, bioRxiv 2019
  4. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation Korkmaz, Gozde, Manber, Zohar, Lopes, Rui, Prekovic, Stefan, Schuurman, Karianne, Kim, Yongsoo, Teunissen, Hans, Flach, Koen, Wit, Elzo de, Galli, Giorgio G, and others, Nucleic acids research 2019
  5. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for the mitogenic function of ER-alpha in breast cancer Korkmaz, Gozde, Manber, Zohar, Marques Lopes, Rui, Prekovic, Stefan, Schuurman, Karianne, Kim, Yongsoo, Teunissen, Hans, Flach, Koen, Wit, Elzo, Galli, Giorgio, and others, Nucleic Acids Research 2019
  6. Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo Kim, Yongsoo, Bismeijer, Tycho, Zwart, Wilbert, Wessels, Lodewyk FA, and Vis, Daniel J Nature communications 2019

2018

  1. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer Severson, Tesa M, Kim, Yongsoo, Joosten, Stacey EP, Schuurman, Karianne, Van Der Groep, Petra, Moelans, Cathy B, Ter Hoeve, Natalie D, Manson, Quirine F, Martens, John W, Van Deurzen, Carolien HM, and others, Nature communications 2018
  2. Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis Stelloo, Suzan, Nevedomskaya, Ekaterina, Kim, Y, Hoekman, L, Bleijerveld, OB, Mirza, T, Wessels, LFA, Weerden, WM, Altelaar, AFM, Bergman, AM, and others, Oncogene 2018
  3. Chemical profiling of primary mesothelioma cultures defines subtypes with different expression profiles and clinical responses Schunselaar, Laurel M, Quispel-Janssen, Josine MMF, Kim, Yongsoo, Alifrangis, Constantine, Zwart, Wilbert, Baas, Paul, and Neefjes, Jacques Clinical Cancer Research 2018
  4. CUEDC1 is a primary target of ERαessential for the growth of breast cancer cells Lopes, Rui, Korkmaz, Gozde, Revilla, Sonia Aristin, Vliet, Romy, Nagel, Remco, Custers, Lars, Kim, Yongsoo, Van Breugel, Pieter C, Zwart, Wilbert, Moumbeini, Behzad, and others, Cancer letters 2018
  5. Identifying biomarkers of anti-cancer drug synergy using multi-task learning Aben, Nanne, Ruiter, Julian R, Bosdriesz, Evert, Kim, Yongsoo, Bounova, Gergana, Vis, Daniel J, Wessels, Lodewyk FA, and Michaut, Magali bioRxiv 2018
  6. Nuclear receptor Nur77 limits the macrophage inflammatory response through transcriptional reprogramming of mitochondrial metabolism Koenis, Duco Steven, Medzikovic, Lejla, Loenen, Pieter Bas, Weeghel, Michel, Huveneers, Stephan, Vos, Mariska, Evers-van Gogh, Ingrid Johanna, Bossche, Jan, Speijer, Dave, Kim, Yongsoo, and others, Cell reports 2018
  7. The Estrogen Receptor chromatin binding landscape in human tumors Joosten, Stacey, Severson, Tesa, Kim, Yongsoo, Schuurman, Karianne, Wessels, Lodewyk, Zwart, Wilbert, and others, In Society for Endocrinology BES 2018 2018
  8. Integrative epigenetic taxonomy of primary prostate cancer Stelloo, Suzan, Nevedomskaya, Ekaterina, Kim, Yongsoo, Schuurman, Karianne, Valle-Encinas, Eider, Lobo, João, Krijgsman, Oscar, Peeper, Daniel Simon, Chang, Seiwon Laura, Feng, Felix Yi-Chung, and others, Nature communications 2018
  9. Optimized ChIP-seq procedure facilitates transcription factor profiling in human tumors. Singh, Abhishek, Schuurman, Karianne, Nevedomskaya, Ekaterina, Stelloo, Suzan, Linder, Simon, Droog, Marjolein, Kim, Yongsoo, Sanders, Joyce, Poel, Henk, Bergman, Andre, and others, 2018

2017

  1. Estrogen receptor αwields treatment-specific enhancers between morphologically similar endometrial tumors Droog, Marjolein, Nevedomskaya, Ekaterina, Dackus, Gwen M, Fles, Renske, Kim, Yongsoo, Hollema, Harry, Mourits, Marian J, Nederlof, Petra M, Van Boven, Hester H, Linn, Sabine C, and others, Proceedings of the National Academy of Sciences 2017

2016

  1. Comparative cistromics reveals genomic cross-talk between FOXA1 and ERαin tamoxifen-associated endometrial carcinomas Droog, Marjolein, Nevedomskaya, Ekaterina, Kim, Yongsoo, Severson, Tesa, Flach, Koen D, Opdam, Mark, Schuurman, Karianne, Gradowska, Patrycja, Hauptmann, Michael, Dackus, Gwen, and others, Cancer research 2016
  2. Neoadjuvant tamoxifen synchronizes ERαbinding and gene expression profiles related to outcome and proliferation Severson, Tesa M, Nevedomskaya, Ekaterina, Peeters, Justine, Kuilman, Thomas, Krijgsman, Oscar, Van Rossum, Annelot, Droog, Marjolein, Kim, Yongsoo, Koornstra, Rutger, Beumer, Inès, and others, Oncotarget 2016
  3. A guide to studying human hair follicle cycling in vivo Oh, Ji Won, Kloepper, Jennifer, Langan, Ewan A, Kim, Yongsoo, Yeo, Joongyeub, Kim, Min Ji, Hsi, Tsai-Ching, Rose, Christian, Yoon, Ghil Suk, Lee, Seok-Jong, and others, Journal of Investigative Dermatology 2016

2015